Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,225.00
Bid: 2,200.00
Ask: 2,250.00
Change: 110.00 (5.16%)
Spread: 50.00 (2.273%)
Open: 2,160.00
High: 2,240.00
Low: 2,160.00
Prev. Close: 2,130.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Significant Contract Win

31 Oct 2017 07:00

RNS Number : 0253V
Craneware plc
31 October 2017
 

Craneware plc

("Craneware", "the Group" or the "Company")

 

Significant Contract Win

 

31 October 2017 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce the renewal and significant expansion of an existing contract with a growing hospital operator in the US.

 

This $6m win sees the extension of a relationship that has been in place since 2007, with the renewal of the customer's existing Value Cycle solutions and the roll out of these same solutions to further facilities that have been recently acquired by this hospital network. The contract is expected to deliver $3.5m of incremental revenue over this new five year term as the hospital network rolls out these solutions at its additional facilities.

 

In accordance with the Company's revenue recognition policy, the majority of the revenue resulting from this contract will be recognised over future periods, adding to the Group's long term visibility of revenue under contract.

 

Keith Neilson, CEO of Craneware plc, commented, "The expansion of this relationship demonstrates the strategic importance of Craneware's Value Cycle solutions to our customers, as they extend their own hospital networks throughout the US. The strength of our solutions and the value they deliver to all customers, including large and complex health systems, allows us to deepen our relationship with our customers as they address the challenges resulting from the continued evolution to the new value based re-imbursement environment.

 

"Having enjoyed our positive working relationship for a decade, we now look forward to continuing to deliver sustainable value throughout this new term."

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

George Sellar

Hilary Buchanan

Robyn McConnachie

Josh Royston

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGMMFGLGLGNZM
Date   Source Headline
25th May 20237:00 amRNSTransaction in Own Shares
24th May 20237:00 amRNSTransaction in Own Shares
23rd May 20237:00 amRNSTransaction in Own Shares
22nd May 20237:00 amRNSTransaction in Own Shares
19th May 20237:00 amRNSTransaction in Own Shares
18th May 20237:00 amRNSTransaction in Own Shares
17th May 20237:00 amRNSTransaction in Own Shares
16th May 20237:02 amRNSTransaction in Own Shares
12th May 20239:21 amRNSTransaction in Own Shares
11th May 20237:00 amRNSTransaction in Own Shares
5th May 202312:35 pmRNSNotification of Major Holdings
28th Apr 20237:00 amRNSTransaction in Own Shares
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in own shares
19th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSBlock Listing Announcement
14th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20237:18 amRNSTransaction in Own Shares
12th Apr 20237:00 amRNSShare Buyback Programme
24th Mar 202311:02 amRNSDividend Currency Election
14th Mar 20237:00 amRNSDirector Share Purchase
6th Mar 20237:00 amRNSInterim Results
13th Feb 20235:15 pmRNSHolding(s) in Company
1st Feb 20233:25 pmRNSDirector Share Purchase
27th Jan 20237:31 amRNSDirector Share Purchase
19th Jan 20232:05 pmRNSSecond Price Monitoring Extn
19th Jan 20232:00 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSTrading Update and Notice of Results
25th Nov 20222:14 pmRNSDividend Currency Election
25th Nov 20229:16 amRNSHolding(s) in Company
21st Nov 202211:40 amRNSGrant of Long Term Incentive Plan Awards
15th Nov 20222:25 pmRNSResult of AGM
15th Nov 20227:00 amRNSAGM Statement and Board Appointment
4th Nov 20221:33 pmRNSHolding(s) in Company
14th Oct 20225:22 pmRNSPosting of Annual Report and Notice of AGM
14th Oct 20227:00 amRNSBlock listing Interim Review
11th Oct 20224:19 pmRNSHolding(s) in Company
10th Oct 202211:10 amRNSHolding(s) in Company
10th Oct 202211:02 amRNSHolding(s) in Company
23rd Sep 20229:06 amRNSVesting of Long Term Incentive Plan Awards
21st Sep 20224:14 pmRNSExercise of Share Options
20th Sep 20227:00 amRNSFinal Results
14th Sep 20223:29 pmRNSChange of Date of Final Results
26th Jul 20227:00 amRNSFY22 Trading Update and Notice of Results
7th Jul 20226:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.